Clark Kensinger1, Antonio Hernandez2, Aihua Bian3, Meagan Fairchild4, Guanhua Chen3, Loren Lipworth5, T Alp Ikizler4, Kelly A Birdwell4. 1. Department of Surgery, Vanderbilt University Medical Center, Nashville, TN, USA. 2. Department of Clinical Anesthesiology, Division of Critical Care Medicine and Cardiothoracic Anesthesiology, Vanderbilt University Medical Center, Nashville, TN, USA. 3. Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN, USA. 4. Division of Nephrology and Hypertension, Vanderbilt University Medical Center, Nashville, TN, USA. 5. Division of Epidemiology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
Abstract
BACKGROUND: Abnormal cardiac morphology is a risk factor for cardiovascular complications in kidney transplant patients. A supraphysiologic level of fibroblast growth factor 23 (FGF-23) has been associated with myocardial hypertrophy in this patient population. Our aim was to evaluate the change in cardiac morphology and function following kidney transplantation and to evaluate the association between the change in FGF-23 concentrations and cardiac morphology. METHODS: We performed a longitudinal, prospective cohort study of 143 kidney transplant recipients (73% male, 75% white) measuring left ventricular (LV) mass index, left atrial (LA) volume index, and ejection fraction (EF) by echocardiography at months 1, 12, and 24 post-transplant. FGF-23 levels were measured at months 1 and 24 post-transplant. RESULTS: Unadjusted and adjusted linear mixed-effects models were used to examine changes in outcomes over time. In the adjusted model, LV mass index (P<.001) and LA volume index (P<.001) decreased and EF (P=.009) increased significantly over time. There was a significant association between decreasing FGF-23 levels and improving LV mass index following transplant (P=.036) in the unadjusted model; however, there was no significant relationship in the adjusted model (0.195). CONCLUSION: Understanding the progression of unique cardiovascular risk factors associated with kidney transplantation may provide potential opportunities to improve survival.
BACKGROUND: Abnormal cardiac morphology is a risk factor for cardiovascular complications in kidney transplant patients. A supraphysiologic level of fibroblast growth factor 23 (FGF-23) has been associated with myocardial hypertrophy in this patient population. Our aim was to evaluate the change in cardiac morphology and function following kidney transplantation and to evaluate the association between the change in FGF-23 concentrations and cardiac morphology. METHODS: We performed a longitudinal, prospective cohort study of 143 kidney transplant recipients (73% male, 75% white) measuring left ventricular (LV) mass index, left atrial (LA) volume index, and ejection fraction (EF) by echocardiography at months 1, 12, and 24 post-transplant. FGF-23 levels were measured at months 1 and 24 post-transplant. RESULTS: Unadjusted and adjusted linear mixed-effects models were used to examine changes in outcomes over time. In the adjusted model, LV mass index (P<.001) and LA volume index (P<.001) decreased and EF (P=.009) increased significantly over time. There was a significant association between decreasing FGF-23 levels and improving LV mass index following transplant (P=.036) in the unadjusted model; however, there was no significant relationship in the adjusted model (0.195). CONCLUSION: Understanding the progression of unique cardiovascular risk factors associated with kidney transplantation may provide potential opportunities to improve survival.
Authors: G A Stewart; J Foster; M Cowan; E Rooney; T McDonagh; H J Dargie; R S Rodger; A G Jardine Journal: Kidney Int Date: 1999-12 Impact factor: 10.612
Authors: Tamara Isakova; Huiliang Xie; Wei Yang; Dawei Xie; Amanda Hyre Anderson; Julia Scialla; Patricia Wahl; Orlando M Gutiérrez; Susan Steigerwalt; Jiang He; Stanley Schwartz; Joan Lo; Akinlolu Ojo; James Sondheimer; Chi-yuan Hsu; James Lash; Mary Leonard; John W Kusek; Harold I Feldman; Myles Wolf Journal: JAMA Date: 2011-06-15 Impact factor: 56.272
Authors: Carsten Rickers; Norbert M Wilke; Michael Jerosch-Herold; Susan A Casey; Prasad Panse; Neeta Panse; Jochen Weil; Andrey G Zenovich; Barry J Maron Journal: Circulation Date: 2005-08-09 Impact factor: 29.690
Authors: D Hernández; J Lacalzada; M Rufino; A Torres; N Martín; A Barragán; Y Barrios; M Macía; E de Bonis; V Lorenzo; A Rodríguez; J M González-Posada; E Salido Journal: Kidney Int Date: 1997-04 Impact factor: 10.612
Authors: P S Parfrey; J D Harnett; R N Foley; G M Kent; D C Murray; P E Barre; R D Guttmann Journal: Transplantation Date: 1995-11-15 Impact factor: 4.939